Global coagulation assays in healthy controls: are there compensatory mechanisms within the coagulation system?
Authors (first, second and last of 8)
Online first articles
Articles not assigned to an issue 145 articles
-
-
A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer
Authors (first, second and last of 5)
-
Incidence of venous thromboembolism among patients with severe COVID-19 requiring mechanical ventilation compared to other causes of respiratory failure: a prospective cohort study
Authors (first, second and last of 8)
-
Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review
Authors (first, second and last of 7)
-
Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor
Authors (first, second and last of 6)
-
-
The allergic myocardial infarction dilemma: is it the anaphylaxis or the epinephrine?
Authors (first, second and last of 4)
-
Clinical and sociodemographic factors associated with anticoagulant use for cancer associated venous thromboembolism
Authors (first, second and last of 8)
-
Calf vein thrombosis outcomes comparing patients with and without cancer
Authors (first, second and last of 11)
-
Association between vitamin D deficiency and serum Homocysteine levels and its relationship with coronary artery disease
Authors (first, second and last of 9)
-
Edoxaban, a direct oral factor Xa inhibitor, ameliorates coagulation, microvascular thrombus formation, and acute liver injury in a lipopolysaccharide-induced coagulopathy model in rats
Authors (first, second and last of 5)
-
-
Small lipid core burden index in patients with stable angina pectoris is also associated with microvascular dysfunction: Insights from intracoronary electrocardiogram
Authors (first, second and last of 5)
-
Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients
Authors (first, second and last of 6)
-
Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy
Authors (first, second and last of 12)
-
-
Nonadministration of pharmacologic venous thromboembolism prophylaxis is less common in hospitalized patients with COVID-19
Authors (first, second and last of 9)
-
-
Different endovascular procedures for stroke with isolated M2-segment MCA occlusion: a real-world experience
Authors (first, second and last of 14)
-
Assessment of provider practices regarding venous thromboembolism management and prevention in pediatric acute leukemia patients
Authors (first, second and last of 6)
-
Anticoagulant therapy management of venous thromboembolism recurrence occurring during anticoagulant therapy: a descriptive study
Authors (first, second and last of 4)
-
-
Association of ABO blood group type with cardiovascular events in COVID-19
Authors (first, second and last of 4)
-
-
Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus
Authors (first, second and last of 7)
-
Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going?
Authors (first, second and last of 5)
-
Comparison of two escalated enoxaparin dosing regimens for venous thromboembolism prophylaxis in obese hospitalized patients
Authors (first, second and last of 4)
-
Evaluation of direct thrombin inhibitors during a critical heparin shortage
Authors (first, second and last of 5)
-
A case of thrombotic thrombocytopenic purpura associated with COVID-19
Authors (first, second and last of 4)
-
Adverse outcomes associated with inappropriate direct oral anticoagulant starter pack prescription among patients with atrial fibrillation: a retrospective claims-based study
Authors (first, second and last of 4)
-
Internuclear ophthalmoplegia as an atypical presentation of lacunar stroke in CADASIL
Authors (first, second and last of 5)
-
Ongoing trials on COVID-19 treatments: please, don’t forget Venous Thromboembolism!
Authors (first, second and last of 4)
-
Massive pulmonary embolism in a patient with nephrotic syndrome and single lung
Authors (first, second and last of 7)
-
-
Pulmonary manifestations of antiphospholipid syndrome: a retrospective analysis of 67 patients
Authors (first, second and last of 8)
-
FVII gene R353Q polymorphism and coronary heart disease: a meta-analysis including 3258 subjects
Authors
-
-
-
Switching between direct oral anticoagulants: a systematic review and meta-analysis
Authors (first, second and last of 4)
-
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox?
Authors (first, second and last of 17)
-
Histopathologic findings of vascular damage after mechanical thrombectomy using stent retriever in canine models
Authors (first, second and last of 4)
-
The risk of venous thromboembolism and physical activity level, especially high level: a systematic review
Authors (first, second and last of 4)
-
The effect of hydroxychloroquine on platelet activation in model experiments
Authors (first, second and last of 7)
-
Predicting mortality, thrombus recurrence and persistence in patients with post-acute myocardial infarction left ventricular thrombus
Authors (first, second and last of 11)
-
Safety and efficacy of direct oral anticoagulants across body mass index groups in patients with venous thromboembolism: a retrospective cohort design
Authors (first, second and last of 5)
-
Downregulating LncRNA XIST attenuated contrast-induced nephropathy injury via regulating miR-133a-3p/NLRP3 axis
Authors (first, second and last of 7)
-
MicroRNA-520d-3p alleviates hypoxia/reoxygenation-induced damage in human cardiomyocytes by targeting ATG-12
Authors (first, second and last of 4)
-
Pulmonary thrombosis in Covid-19: before, during and after hospital admission
Authors (first, second and last of 8)
-
Clinical validation of immunoassay HemosIL® AcuStar HIT-IgG (PF4-H) in the diagnosis of Heparin-induced thrombocytopenia
Authors (first, second and last of 8)
-
Cangrelor in addition to standard therapy reduces cardiac damage and inflammatory markers in patients with ST-segment elevation myocardial infarction
Authors (first, second and last of 8)
